Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 285

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 285
---
 |                                 | 98 |     |       | 160 |

<div align='center'>F-4 3</div>

All of the stock option expense for the periods ended September 30, 2024, and 2023, has been recognized as additional paid in capital. The aggregate intrinsic value of stock options outstanding as well as stock options exercisable was nil as of September 30, 2024, and 2023, respectively. As of September 30, 2024, there was $ 224 in unrecognized compensation expense that will be recognized over the next 1.8 years.

The following table sets forth changes in unvested stock options under all plans:

| Unvested at June 30, 2024      |     | Number ofOptions(in thousands) |  3 |   |     | Weightedaverageexerciseprice$ | 545.01 |
|:-------------------------------|:----|:-------------------------------|---:|:--|:----|:------------------------------|-------:|
| Vested                         |     |                                | (1 | ) |     |                               | 435.36 |
| Unvested at September 30, 2024 |     |                                |  2 |   |     |                               | 579.79 |

The aggregate intrinsic value of unvested stock options at September 30, 2024, was nil (2023 - nil ). The unvested stock options have a remaining weighted average contractual term of 7.16 years (2023 - 9.26 ).

Restricted stock units

During the three months ended September 30, 2024, the Company recognized a total of $ 3 (2023 - $ 47 ) in compensation expense related to RSUs.

| Balance - June 30, 2024           |     | Number ofRSU(in thousands) | 2  |   |
|:----------------------------------|:----|:---------------------------|:---|:--|
| Vesting of restricted stock units |     |                            | (2 | ) |
| Balance - September 30, 2024      |     |                            | —  |   |

Common stock warrants

The following table sets forth changes in outstanding common stock warrants:

|                                        |     | Number ofWarrants(in thousands) |    |   |     | Weightedaverageexerciseprice$ |          |
| Balance - June 30, 2024                |     |                                 | 19 |   |